Latanoprostene bunod
Glaucoma · Rx
RxGlaucomaGlaucoma Pga Turquoise cap
| Strength | 0.024% |
|---|---|
| Typical quantity | 2.5-5 mL bottle (brand only, no generic) |
| Cash cost / month | High · ~$100-350 |
| Drug class | Prostaglandin analog + nitric oxide donor |
| Mechanism of action | Metabolized to latanoprost acid (uveoscleral outflow) plus butanediol mononitrate, which releases nitric oxide to relax the trabecular meshwork and increase conventional outflow, dual mechanism. |
| Indication / reason for use | Open-angle glaucoma and ocular hypertension. |
| Usual adult dosing | 1 drop once daily in the evening. |
| Preservative | BAK 0.02% |
| Contact lenses | Remove lenses; reinsert after 15 minutes. |
| Common / important adverse effects | Conjunctival hyperemia, eye irritation, pain on instillation, lash and pigment changes. |
| Contraindications & cautions | As for the PGA class. |
| Pregnancy / lactation | Avoid where possible. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Vyzulta |
| Practice notes | Modestly greater IOP lowering than latanoprost in head-to-head studies. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.